Recent Progress in Technetium-99m-Labeled Nanoparticles for Molecular Imaging and Cancer Therapy
Nanotechnology has played a tremendous role in molecular imaging and cancer therapy. Over the last decade, scientists have worked exceptionally to translate nanomedicine into clinical practice. However, although several nanoparticle-based drugs are now clinically available, there is still a vast dif...
Guardado en:
Autores principales: | Sajid Mushtaq, Asia Bibi, Jung Eun Park, Jongho Jeon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a400287c22a849ee9e87c2e47e12b81a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes
por: De Silva L, et al.
Publicado: (2019) -
Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations
por: Ghoreishi SM, et al.
Publicado: (2018) -
Development of 99mTc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer
por: Rainone P, et al.
Publicado: (2017) -
Synthesis and Biodistribution of <sup>99m</sup>Tc-Labeled PLGA Nanoparticles by Microfluidic Technique
por: Michela Varani, et al.
Publicado: (2021) -
99mTc-Radiolabeled Silica Nanocarriers for Targeted Detection and Treatment of HER2-Positive Breast Cancer
por: Rainone P, et al.
Publicado: (2021)